vs

Side-by-side financial comparison of ASP Isotopes Inc. (ASPI) and Dow Inc. (DOW). Click either name above to swap in a different company.

Dow Inc. is the larger business by last-quarter revenue ($9.5B vs $16.7M, roughly 567.8× ASP Isotopes Inc.). On growth, ASP Isotopes Inc. posted the faster year-over-year revenue change (1295.7% vs -9.3%). Over the past eight quarters, ASP Isotopes Inc.'s revenue compounded faster (345.2% CAGR vs -6.9%).

ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.

The Dow Chemical Company is an American multinational corporation headquartered in Midland, Michigan, United States. The company was among the three largest chemical producers in the world in 2021. It is the operating subsidiary of Dow Inc., a publicly traded holding company incorporated under Delaware law.

ASPI vs DOW — Head-to-Head

Bigger by revenue
DOW
DOW
567.8× larger
DOW
$9.5B
$16.7M
ASPI
Growing faster (revenue YoY)
ASPI
ASPI
+1305.0% gap
ASPI
1295.7%
-9.3%
DOW
Faster 2-yr revenue CAGR
ASPI
ASPI
Annualised
ASPI
345.2%
-6.9%
DOW

Income Statement — Q4 2025 vs Q1 2026

Metric
ASPI
ASPI
DOW
DOW
Revenue
$16.7M
$9.5B
Net Profit
Gross Margin
12.5%
5.8%
Operating Margin
Net Margin
Revenue YoY
1295.7%
-9.3%
Net Profit YoY
-586.8%
EPS (diluted)
$-2.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPI
ASPI
DOW
DOW
Q1 26
$9.5B
Q4 25
$16.7M
$9.5B
Q3 25
$4.9M
$10.0B
Q2 25
$1.2M
$10.1B
Q1 25
$1.1M
$10.4B
Q4 24
$1.2M
$10.4B
Q3 24
$1.1M
$10.9B
Q2 24
$1.0M
$10.9B
Net Profit
ASPI
ASPI
DOW
DOW
Q1 26
Q4 25
$-1.5B
Q3 25
$-12.9M
$62.0M
Q2 25
$-75.2M
$-835.0M
Q1 25
$-8.5M
$-307.0M
Q4 24
$-35.0M
Q3 24
$-7.4M
$214.0M
Q2 24
$-8.9M
$439.0M
Gross Margin
ASPI
ASPI
DOW
DOW
Q1 26
5.8%
Q4 25
12.5%
5.8%
Q3 25
8.7%
7.3%
Q2 25
47.7%
5.8%
Q1 25
29.7%
6.4%
Q4 24
50.7%
9.0%
Q3 24
27.0%
9.8%
Q2 24
41.2%
12.1%
Operating Margin
ASPI
ASPI
DOW
DOW
Q1 26
Q4 25
-16.4%
Q3 25
-306.1%
0.7%
Q2 25
-998.8%
-6.5%
Q1 25
-721.9%
-3.6%
Q4 24
2.1%
Q3 24
-499.6%
3.0%
Q2 24
-729.5%
5.6%
Net Margin
ASPI
ASPI
DOW
DOW
Q1 26
Q4 25
-15.6%
Q3 25
-263.7%
0.6%
Q2 25
-6271.7%
-8.3%
Q1 25
-768.1%
-2.9%
Q4 24
-0.3%
Q3 24
-676.2%
2.0%
Q2 24
-868.8%
4.0%
EPS (diluted)
ASPI
ASPI
DOW
DOW
Q1 26
$-2.16
Q4 25
$-2.16
Q3 25
$-0.15
$0.08
Q2 25
$-1.03
$-1.18
Q1 25
$-0.12
$-0.44
Q4 24
$-0.08
Q3 24
$-0.12
$0.30
Q2 24
$-0.24
$0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPI
ASPI
DOW
DOW
Cash + ST InvestmentsLiquidity on hand
$333.3M
$3.8B
Total DebtLower is stronger
$14.4M
$17.8B
Stockholders' EquityBook value
$204.2M
$16.0B
Total Assets
$498.0M
$58.5B
Debt / EquityLower = less leverage
0.07×
1.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPI
ASPI
DOW
DOW
Q1 26
$3.8B
Q4 25
$333.3M
$3.8B
Q3 25
$113.9M
$4.6B
Q2 25
$67.7M
$2.4B
Q1 25
$56.0M
$1.5B
Q4 24
$61.9M
$2.2B
Q3 24
$51.6M
$2.9B
Q2 24
$3.3B
Total Debt
ASPI
ASPI
DOW
DOW
Q1 26
$17.8B
Q4 25
$14.4M
$17.8B
Q3 25
$13.9M
$17.7B
Q2 25
$16.2B
Q1 25
$15.9B
Q4 24
$2.4M
$15.7B
Q3 24
$16.2B
Q2 24
$16.0B
Stockholders' Equity
ASPI
ASPI
DOW
DOW
Q1 26
$16.0B
Q4 25
$204.2M
$16.0B
Q3 25
$74.1M
$17.5B
Q2 25
$25.2M
$17.2B
Q1 25
$42.5M
$16.8B
Q4 24
$47.9M
$17.4B
Q3 24
$38.7M
$18.3B
Q2 24
$11.0M
$18.3B
Total Assets
ASPI
ASPI
DOW
DOW
Q1 26
$58.5B
Q4 25
$498.0M
$58.5B
Q3 25
$225.9M
$61.0B
Q2 25
$135.9M
$59.0B
Q1 25
$90.9M
$57.5B
Q4 24
$94.3M
$57.3B
Q3 24
$84.1M
$59.4B
Q2 24
$54.8M
$58.5B
Debt / Equity
ASPI
ASPI
DOW
DOW
Q1 26
1.12×
Q4 25
0.07×
1.12×
Q3 25
0.19×
1.01×
Q2 25
0.94×
Q1 25
0.95×
Q4 24
0.05×
0.91×
Q3 24
0.88×
Q2 24
0.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPI
ASPI
DOW
DOW
Operating Cash FlowLast quarter
$-37.8M
Free Cash FlowOCF − Capex
$-47.4M
FCF MarginFCF / Revenue
-284.7%
Capex IntensityCapex / Revenue
57.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-74.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPI
ASPI
DOW
DOW
Q1 26
Q4 25
$-37.8M
$284.0M
Q3 25
$-8.9M
$1.1B
Q2 25
$-7.9M
$-470.0M
Q1 25
$-3.2M
$91.0M
Q4 24
$-16.7M
$814.0M
Q3 24
$-4.8M
$800.0M
Q2 24
$-5.1M
$836.0M
Free Cash Flow
ASPI
ASPI
DOW
DOW
Q1 26
Q4 25
$-47.4M
$-284.0M
Q3 25
$-12.0M
$563.0M
Q2 25
$-9.7M
$-1.1B
Q1 25
$-5.5M
$-594.0M
Q4 24
$-26.4M
$47.0M
Q3 24
$-9.3M
$64.0M
Q2 24
$-7.7M
$113.0M
FCF Margin
ASPI
ASPI
DOW
DOW
Q1 26
Q4 25
-284.7%
-3.0%
Q3 25
-245.5%
5.6%
Q2 25
-809.4%
-11.2%
Q1 25
-497.4%
-5.7%
Q4 24
-2209.3%
0.5%
Q3 24
-857.3%
0.6%
Q2 24
-757.8%
1.0%
Capex Intensity
ASPI
ASPI
DOW
DOW
Q1 26
Q4 25
57.9%
6.0%
Q3 25
64.4%
5.7%
Q2 25
150.1%
6.6%
Q1 25
209.6%
6.6%
Q4 24
810.5%
7.4%
Q3 24
412.3%
6.8%
Q2 24
256.5%
6.6%
Cash Conversion
ASPI
ASPI
DOW
DOW
Q1 26
Q4 25
Q3 25
18.18×
Q2 25
Q1 25
Q4 24
Q3 24
3.74×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons